Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA4 | P22748 | 1/20 | 0.37 |
| ▸ | CA6 | P23280 | 1/20 | 0.37 |
| ▸ | CA5A | P35218 | 1/20 | 0.37 |
| ▸ | CA7 | P43166 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.37 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5362613 | 0.92 | CA1 (0.39) | CA12CA1CA2CA4CA6 | |
| SCHEMBL3894118 | 0.82 | CYP3A4 (0.45) | ALDH1A1PKMSMN1; SMN2KDM4E | |
| SCHEMBL5847207 | 0.81 | ALDH1A1 (0.43) | CA12CA1CA2CA4CA6 | |
| SCHEMBL29449219 | 0.79 | ALDH1A1 (0.46) | CA12CA1CA2CA4CA6 | |
| SCHEMBL40549 | 0.79 | ALDH1A1 (0.46) | CA12CA1CA2CA4CA6 | |
| SCHEMBL18726208 | 0.79 | FFAR4 (0.38) | ALDH1A1PKMSMN1; SMN2KDM4EHPGD | |
| SCHEMBL5845870 | 0.79 | CYP3A4 (0.42) | CA12CA1CA2CA4CA6 | |
| SCHEMBL16155869 | 0.78 | GAA (0.42) | CA1CA2CA9 | |
| Hydrochloric Acid SCHEMBL11772004 | 0.78 | ALDH1A1 (0.44) | CA12CA1CA2CA4CA6 | |
| SCHEMBL7102669 | 0.77 | SMN1; SMN2 (0.44) | CA12CA1CA2CA4CA6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7041852-B2 | Perfluoroalkylanilines | BAYER CHEMICALS AG (DE) | 2006-05-09 | — | — | US | claimed |
| US-20040152898-A1 | Perfluoroalkylanilines | LANXESS DEUTSCHLAND GMBH (DE) | 2004-08-05 | — | — | US | claimed |
| EP-1418171-A1 | Perfluoroalkylanilins | Bayer Chemicals AG (DE) | 2004-05-12 | — | — | EP | claimed |
| EP-3556744-B1 | INSECTICIDAL COMPOUNDS | SYNGENTA PARTICIPATIONS AG (CH) | 2022-06-01 | — | — | EP | disclosed |
| EP-3087052-B1 | INSECTICIDAL COMPOUNDS | SYNGENTA PARTICIPATIONS AG (CH) | 2019-11-20 | — | — | EP | disclosed |
| EP-3556744-A1 | INSECTICIDAL COMPOUNDS | SYNGENTA PARTICIPATIONS AG (CH) | 2019-10-23 | — | — | EP | disclosed |
| US-9750246-B2 | Insecticidal compounds | SYNGENTA PARTICIPATIONS AG (CH) | 2017-09-05 | — | — | US | disclosed |
| US-9750246-B2 | Insecticidal compounds | SYNGENTA PARTICIPATIONS AG (CH) | 2017-09-05 | — | — | US | disclosed |
| US-20170000121-A1 | INSECTICIDAL COMPOUNDS | SYNGENTA PARTICIPATIONS AG (CH) | 2017-01-05 | — | — | US | disclosed |
| EP-1418171-B1 | Verfahren zur Herstellung von Perfluoroalkylanilins | SALTIGO GMBH (DE) | 2011-12-14 | — | — | EP | disclosed |
| US-7041852-B2 | Perfluoroalkylanilines | BAYER CHEMICALS AG (DE) | 2006-05-09 | — | — | US | disclosed |
| US-20040152898-A1 | Perfluoroalkylanilines | LANXESS DEUTSCHLAND GMBH (DE) | 2004-08-05 | — | — | US | disclosed |
| EP-1418171-A1 | Perfluoroalkylanilins | Bayer Chemicals AG (DE) | 2004-05-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170000121-A1 | INSECTICIDAL COMPOUNDS | ACHE, NIT2, CHRM1 | CA12 3992/4885CA1 1233/4885CA2 339/4885 |
| US-20040152898-A1 | Perfluoroalkylanilines | PFAS, AFF2, AFF4 | CA12 4612/4885CA1 4510/4885CA2 4393/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.